We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AzurRx BioPharma Inc | NASDAQ:AZRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | 3.41 | 3.51 | 0 | 01:00:00 |
Effective April 29, 2020, Mr. Johan (Thijs) Spoor provided AzurRx BioPharma, Inc. (the "Company") with notice of his resignation from the Company's board of directors, effective immediately. The resignation of Mr. Spoor was not due to any disagreement on any matter relating to the Company's operations, policies or practices.
In addition, Mr. Spoor also forfeited the right to receive 241,667 earned, but unissued shares of restricted stock in connection with his resignation.
AzurRx BioPharma, Inc. |
By: | /s/ James Sapirstein |
|
|
Name: James Sapirstein | |
Title: President and Chief Executive Officer |
1 Year AzurRx BioPharma Chart |
1 Month AzurRx BioPharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions